Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Clinical Trial in Japan for Reconstruction of Obstructive Lesions of the Superficial Femoral Artery or Proximal Popliteal Artery by Bard LifeStent.

NCT01746550 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.

NCT NCT01746550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01746550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Clinical Trial in Japan for Reconstruction of Obstructive Lesions of the Superficial Femoral Artery or Proximal Popliteal Artery by Bard LifeStent.
Lead sponsor
C. R. Bard
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2012
Completion date
October 31, 2018
Enrollment
70 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive disease